Tuesday, January 21, 2014


Discovery of Quantum Vibrations in 'Microtubules' Inside Brain Neurons Supports Controversial Theory of Consciousness


Jan. 16, 2014 — A review and update of a controversial 20-year-old theory of consciousness published in Physics of Life Reviews claims that consciousness derives from deeper level, finer scale activities inside brain neurons. The recent discovery of quantum vibrations in "microtubules" inside brain neurons corroborates this theory, according to review authors Stuart Hameroff and Sir Roger Penrose. They suggest that EEG rhythms (brain waves) also derive from deeper level microtubule vibrations, and that from a practical standpoint, treating brain microtubule vibrations could benefit a host of mental, neurological, and cognitive conditions.

The theory, called "orchestrated objective reduction" ('Orch OR'), was first put forward in the mid-1990s by eminent mathematical physicist Sir Roger Penrose, FRS, Mathematical Institute and Wadham College, University of Oxford, and prominent anesthesiologist Stuart Hameroff, MD, Anesthesiology, Psychology and Center for Consciousness Studies, The University of Arizona, Tucson. They suggested that quantum vibrational computations in microtubules were "orchestrated" ("Orch") by synaptic inputs and memory stored in microtubules, and terminated by Penrose "objective reduction" ('OR'), hence "Orch OR." Microtubules are major components of the cell structural skeleton.

Orch OR was harshly criticized from its inception, as the brain was considered too "warm, wet, and noisy" for seemingly delicate quantum processes.. However, evidence has now shown warm quantum coherence in plant photosynthesis, bird brain navigation, our sense of smell, and brain microtubules. The recent discovery of warm temperature quantum vibrations in microtubules inside brain neurons by the research group led by Anirban Bandyopadhyay, PhD, at the National Institute of Material Sciences in Tsukuba, Japan (and now at MIT), corroborates the pair's theory and suggests that EEG rhythms also derive from deeper level microtubule vibrations. In addition, work from the laboratory of Roderick G. Eckenhoff, MD, at the University of Pennsylvania, suggests that anesthesia, which selectively erases consciousness while sparing non-conscious brain activities, acts via microtubules in brain neurons.

"The origin of consciousness reflects our place in the universe, the nature of our existence. Did consciousness evolve from complex computations among brain neurons, as most scientists assert? Or has consciousness, in some sense, been here all along, as spiritual approaches maintain?" ask Hameroff and Penrose in the current review. "This opens a potential Pandora's Box, but our theory accommodates both these views, suggesting consciousness derives from quantum vibrations in microtubules, protein polymers inside brain neurons, which both govern neuronal and synaptic function, and connect brain processes to self-organizing processes in the fine scale, 'proto-conscious' quantum structure of reality."

After 20 years of skeptical criticism, "the evidence now clearly supports Orch OR," continue Hameroff and Penrose. "Our new paper updates the evidence, clarifies Orch OR quantum bits, or "qubits," as helical pathways in microtubule lattices, rebuts critics, and reviews 20 testable predictions of Orch OR published in 1998 -- of these, six are confirmed and none refuted."

An important new facet of the theory is introduced. Microtubule quantum vibrations (e.g. in megahertz) appear to interfere and produce much slower EEG "beat frequencies." Despite a century of clinical use, the underlying origins of EEG rhythms have remained a mystery. Clinical trials of brief brain stimulation aimed at microtubule resonances with megahertz mechanical vibrations using transcranial ultrasound have shown reported improvements in mood, and may prove useful against Alzheimer's disease and brain injury in the future.

Lead author Stuart Hameroff concludes, "Orch OR is the most rigorous, comprehensive and successfully-tested theory of consciousness ever put forth. From a practical standpoint, treating brain microtubule vibrations could benefit a host of mental, neurological, and cognitive conditions."

The review is accompanied by eight commentaries from outside authorities, including an Australian group of Orch OR arch-skeptics. To all, Hameroff and Penrose respond robustly.

Penrose, Hameroff and Bandyopadhyay will explore their theories during a session on "Microtubules and the Big Consciousness Debate" at the Brainstorm Sessions, a public three-day event at the Brakke Grond in Amsterdam, the Netherlands, January 16-18, 2014. They will engage skeptics in a debate on the nature of consciousness, and Bandyopadhyay and his team will couple microtubule vibrations from active neurons to play Indian musical instruments. "Consciousness depends on anharmonic vibrations of microtubules inside neurons, similar to certain kinds of Indian music, but unlike Western music which is harmonic," Hameroff explains.

Discovery of quantum vibrations in 'microtubules' corroborates theory of consciousness

Monday, January 6, 2014

DARPA BRAIN IMPLANTS FOR BRAIN-MACHINE INTERFACES


Although being touted as a means by which to "HELP" - the DoD NEVER does anything for just ONE PURPOSE.  They look at the Advances in Controlling OTHER PEOPLES BRAIN FUNCTIONS as a MEANS OF CONTROL - 

In the case of the Solicitation for Funding by DARPA to place brain implants into "subjects", the Technical Areas have to do with Monitoring Neural Output, and then using existing or new BIO-technological means by which to "stimulate aka ZAP neurons" or a series of neurons in order to '"elevate symptoms." aka control behavioral functions....

DARPA seeks to develop a new understanding of complex, systems-based disorders of the brain. A major goal of this effort is to deliver a platform technology for precise therapy in humans living with neuropsychiatric and neurologic disease, including veterans and active duty soldiers suffering from mental health issues. Methods developed through this program will use neural recording and stimulation to close the loop on therapeutic treatment in individuals who receive minimal benefits from currently available treatments. This program could lead to improved knowledge of multiple neural subnetworks of the brain that are involved in disease and illness. This program combines novel device development, complex modeling of behaving human neural systems, clinical neurology, and animal research in order to advance the understanding and translation of safe, effective neurotechnological therapies.

This is nothing more than Coercive Mechanical manipulation of Cognitive, Motor, Central Nervous System, and/or Behavioral Functions.  aka MIND CONTROL

Thus, this is a means by which to come out of the black ops closet, and claim this is for the purpose of "ideas" or "proof of principle" but in reality they have long since and criminally been experimenting on Human Subject in the form of Targeted Individual's for YEARS.  

This approach should advance neuropsychiatry beyond the realm of dialogue-driven observations and 
resultant trial and error and into the realm of therapy driven by quantifiable characteristics of neural 
state. In doing so, SUBNETS will create one of the most comprehensive datasets of systems-based brain 
activity ever recorded.

For purposes of this program, DARPA is specifically interested in evaluating the underlying systems, 
which contribute to the following conditions as described by the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-V):
• • • •
Post-Traumatic Stress Disorder (PTSD) Major Depression Borderline Personality Disorder General 
Anxiety Disorder

Additionally, DARPA is interested in evaluating the representation in the central nervous system of the 
following three conditions:
........
TBI Substance Abuse/Addiction Fibromyalgia/Chronic Pain

HOW MANY FIELDS ARE INVOLVED 
DARPA expects that successful teams will span across disciplines including psychiatry, neurosurgery, 
microelectronics, neuroscience, statistics, and computational modeling. All teams should have access to 
sufficient clinical populations to allow the recruitment of volunteer research participants from each of 
the diseases and disorders of interest. Teams that propose to Technical Area Two should have familiarity
with the Food and Drug Administration (FDA) regulations regarding implanted devices. Teams that 
propose to Technical Area Three should have currently operating facilities for advanced animal 
modeling, such as non-human primate research.

Technical Area One (TA One):  aka (MAPPING THE BRAIN VIA NEURAL OUTPUT)
TA One is comprised of clinical trials in order to establish mechanistic models of awake, behaving 
human brain activity. In Phase One, investigators should propose a method to establish models for 
two neuropsychiatric systems and one neurological system. These methods should demonstrate the 
capacity to record neural signals from participants and associate these signals with behavior. 
Additionally, models should describe how stimulation could, without impacting behavior or symptoms 
not related to their primary disease outcomes, effect research participants and provide alleviation from 
their disease- related symptoms. In Phase Two, investigators will be responsible for modeling the 
additional two neuropsychiatric systems and the final two neurological systems. DARPA is particularly
 interested in proposals that advance understanding of mechanisms of change, plasticity, or adaptation 
in neural systems over time in response to stimulation.


Technical Area Two (TA Two):  AKA ( ZAPPING the Brain to alter cognitive, motor, central 
nervous system and/or behaivoral functions)
TA Two encompasses the hardware development component in order to create safe and effective sensing
 and stimulation systems. These systems may be based on currently available commercial technology, or
 take on a new form-factor. Goals and metrics in this TA include the fabrication and testing of novel 
devices, ensuring that the devices are amenable to the functionalization of models built in TA One, 
and advancing the state-of- the art for weight, power, and actuation. Additionally, TA Two will include
tasks related to device acceptance by both the FDA and consultation with potential end users from the
 clinical and patient communities.

DARPA is not interested in simple modifications to existing technologies, but rather seeks to significantly 
advance the capabilities of neural recording beyond those offered from current commercial-off-the-shelf 
devices. For purposes of this proposal, proposers should not limit their understanding of neural recording 
to the ability to record electrical potentials generated through synaptic activity, but may also address other 
methods of recording neural activity, such as methods for measuring neurotransmitters. Proposals which 
outline methods for recording non-electrical activity of neurons must also outline an appropriate FDA 
strategy, to include package submission and Investigational Device Exemption (IDE) approval in Phase 
One and package modifications in Phase Two.

WHAT THIS DARPA SOLICITATION DOES IS LEGALLY VALIDATE THE CRIMINAL 
CLAIMS I MADE ABOUT WHAT HAS ALREADY BEEN GOING ON - VIA A SENT
 EMAIL TO THE LAW AND NEUROSCIENCE PROJECT OUTLINING BASICALLY 
EVERYTHING THAT IS FROM THIS DEFENSE ADVANCED RESEARCH PROJECT 
AGENCY 2013/2014 FUNDING SOLICITATION 

THIS EMAIL WAS SENT TO: THE LAW and NEUROSCIENCE PROJECT :  ON FEBRUARY 3, 2010 - 






































From the DARPA Funding Proposal of October 24, 2013 DARPA-BAA-14-09
Systems-Based Neurotechnology for Emerging Therapies (SUBNETS):

Ethical, Legal, and Societal Implications (ELSI) of Neurotechnology for Disease Alleviation:
DARPA maintains its commitment to ensuring that efforts funded under this BAA adhere to ethical 
and legal regulations currently in place for federally and DoD-funded research involving human and
 animal use. Program developments will be discussed with the Presidential Commission for the Study 
of Bioethical Issues, which advises the President on bioethical issues that may emerge as a
consequence of advances in biomedical science and technology. Respondents to this BAA should 
address potential ethical, legal, and societal implications of the proposed technology. Specifically, 
proposers should address patient populations who may benefit from the use of a novel technology 
to address symptom severity.

This is what I wrote to the Presidential Commission for the Study of Bioethical Issues, 
and sent to them via email for my Public Comment at their February 2-3, 2012 
Gathering.SHOWS - Before even this Defense Advanced Research Project Agency
 (DARPA) funding solicitation, Target's such as myself, had LONG SINCE OUTLINED 
what was being done to them ILLEGALLY, CRIMINALLY, as 
NON CONSENSUAL HUMAN GUINEA PIGS.